NCT00489346已完成3 期
A Double-Blind, Randomized, Double-Dummy, Multicenter Study to Evaluate and Compare Oral Montelukast and Inhaled Fluticasone in the Control of Asthma for 6- to 14-Year-Olds With Mild Persistent Asthma
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 994
- 主要终点
- Improvement of asthma with MK0476 and Fluticasone as measured by number of asthma rescue-free days
研究概览
简要总结
A study to evaluate MK0476 and Fluticasone to control asthma in patients with mild persistent asthma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 6 Years 至 14 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient is male or female, 6-14 years of age with mild persistent asthma
- •Patient has a history of the following symptoms: wheezing, chest tightness, cough, etc.
- •Patient has asthma diagnosed by a doctor
排除标准
- •Patient is hospitalized
- •Patient has had major surgery or participated in another clinical trial in the last 4 weeks
- •Patient has been on a breathing tube for asthma
结局指标
主要结局
Improvement of asthma with MK0476 and Fluticasone as measured by number of asthma rescue-free days
时间窗: Duration of Trial
次要结局
- Improved effect of MK0476 and fluticasone on FEV1 values(Duration of Trial)
研究者
相似试验
已完成
3 期
A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)AsthmaNCT00700661Organon and Co500
终止
2 期
The Effect of MK0633 in Patients With Chronic Asthma (0633-007)AsthmaNCT00404313Merck Sharp & Dohme LLC688
已完成
2 期
A Study of MK0359 in Patients With Chronic Asthma (0359-013)AsthmaNCT00482898Merck Sharp & Dohme LLC56
终止
2 期
An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled AsthmaAsthmaNCT02219048Pfizer51
撤回
1 期
Safety and Efficacy of QAX576 in Adults With Moderate Persistent Allergic AsthmaAsthmaNCT00598104Novartis